A DaVita HealthCare Partners subsidiary is under federal investigation for possible violation of the False Claims Act. RMS Lifeline Inc., which does business under the name Lifeline Vascular Access, has received a civil investigative demand from the Justice Department relating to two vascular access centers it operates in Florida. The department is conducting a False Claims Act investigation and is reviewing the medical necessity of angiograms performed on 10 patients, covering a period from Jan. 1, 2008 through the present, according to DaVita’s Nov. 18 filing with the U.S. Securities and Exchange Commission.

Read also: Court finds Fresenius did not violate False Claims Act in overfill case

“The company maintains policies and procedures to promote compliance with the False Claims Act and other applicable laws and regulations, and intends to cooperate with the government,” DaVita said in the form. “The company cannot predict, however, when this investigation will be resolved, its eventual outcome or scope, or its potential impact on the company.”